EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guerin


Cambier S., Sylvester R. J., Collette L., Gontero P., Brausi M. A., van Andel G., ...Daha Fazla

EUROPEAN UROLOGY, cilt.69, sa.1, ss.60-69, 2016 (SCI-Expanded) identifier identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 69 Sayı: 1
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1016/j.eururo.2015.06.045
  • Dergi Adı: EUROPEAN UROLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.60-69
  • Anahtar Kelimeler: Non-muscle-invasive bladder cancer, Prognostic factors, Recurrence, Progression, Survival, Bacillus Calmette-Guerin, TRANSITIONAL-CELL CARCINOMA, PROGNOSTIC-FACTORS, FOLLOW-UP, TA, T1, IMMUNOTHERAPY, INSTILLATIONS, TABLES, MODEL
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Evet

Özet

Background: There are no prognostic factor publications on stage Ta-T1 non-muscle-invasive bladder cancer (NMIBC) treated with 1-3 yr of maintenance bacillus Calmette-Guerin (BCG).